journal article·2026-03Open access

PTG‐Dependent Glycogen Metabolic Dysfunction Drives Impaired Adipose Browning: A Novel Mechanism Linking PM 2.5 to Metabolic Disorders

Limin Wang, Renjie Hu, Yanxi Chai, Ping He, Sanduo Li, Lisha Zhao, Wenbin Zhao, Lu Zhang, Li Qin, Ran Li, Xiaoli Hou, Qinghua Sun, Cuiqing Liu

Advanced Science· Volume 13· Issue 16

Abstract

ABSTRACT Fine particulate matter (PM 2.5 ) contributes to metabolic dysfunction, but its effects on adipose tissue browning remain unclear. Here, we showed that PM 2.5 exposure inhibited inguinal white adipose tissue (iWAT) browning by downregulating protein targeting to glycogen (PTG), disrupting glycogen homeostasis. PTG overexpression in iWAT restored glycogen metabolism, thermogenesis, and mitochondrial function, reversing PM 2.5 ‐induced impairment in iWAT browning and metabolic disorders. Mechanistically, PTG negatively regulated vascular endothelial growth factor B (VEGFB), and VEGFB knockdown rescued browning. Activation of β3‐adrenergic receptor (ADRB3) mitigated PM 2.5 ’s effects by restoring PTG and normalizing VEGFB, defining the ADRB3‐PTG‐VEGFB axis as central to PM 2.5 ‐induced metabolic dysfunction. Our findings identify adipose glycogen metabolism as a target for countering environmental metabolic disruption.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Adipose Tissue and Metabolism · Adipokines, Inflammation, and Metabolic Diseases · Cardiovascular Disease and Adiposity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Public Health Zhejiang Chinese Medical University Hangzhou Zhejiang China

Zhejiang International Science and Technology Cooperation Base of Air Pollution and Health Hangzhou Zhejiang China

Academy of Chinese Medical Sciences Zhejiang Chinese Medical University Hangzhou Zhejiang China

Funding

National Natural Science Foundation of China

References (66)

Show source-provided references
1. 10.1016/j.envint.2015.10.01610.1016/j.envint.2015.10.016 ↗
2. 10.1016/j.jacc.2019.12.03110.1016/j.jacc.2019.12.031 ↗
3. 10.1146/annurev‐med‐042220‐01154910.1146/annurev‐med‐042220‐011549 ↗
4. 10.1016/j.jhazmat.2024.13465910.1016/j.jhazmat.2024.134659 ↗
5. 10.1186/s12989‐014‐0053‐510.1186/s12989‐014‐0053‐5 ↗
6. 10.1016/j.envint.2020.10595010.1016/j.envint.2020.105950 ↗
7. 10.1289/EHP794410.1289/EHP7944 ↗
8. 10.1186/s12989‐017‐0187‐310.1186/s12989‐017‐0187‐3 ↗
9. 10.2337/dc23‐215310.2337/dc23‐2153 ↗
10. 10.1289/EHP968810.1289/EHP9688 ↗
11. 10.1289/ehp.130684110.1289/ehp.1306841 ↗
12. 10.1021/acs.est.2c0156810.1021/acs.est.2c01568 ↗
13. 10.1007/s00394‐018‐1790‐210.1007/s00394‐018‐1790‐2 ↗
14. 10.1038/nrendo.2013.20410.1038/nrendo.2013.204 ↗
15. 10.1038/nrm.2016.9610.1038/nrm.2016.96 ↗
16. 10.1038/srep1797710.1038/srep17977 ↗
17. 10.1016/j.cmet.2024.05.00510.1016/j.cmet.2024.05.005 ↗
18. 10.1038/s41467‐023‐43418‐510.1038/s41467‐023‐43418‐5 ↗
19. 10.1016/j.heliyon.2024.e2893610.1016/j.heliyon.2024.e28936 ↗
20. 10.1016/j.nantod.2024.10216710.1016/j.nantod.2024.102167 ↗
21. 10.1126/sciadv.aau604410.1126/sciadv.aau6044 ↗
22. 10.1016/j.carbpol.2019.11552610.1016/j.carbpol.2019.115526 ↗
23. 10.1111/jpi.1282310.1111/jpi.12823 ↗
24. 10.3390/ijerph1407078710.3390/ijerph14070787 ↗
25. 10.1016/0003‐9861(64)90374‐110.1016/0003‐9861(64)90374‐1 ↗
26. 10.1126/science.275.5305.147510.1126/science.275.5305.1475 ↗
27. 10.1016/j.ibror.2016.10.00210.1016/j.ibror.2016.10.002 ↗
28. 10.1038/s41586‐021‐04019‐810.1038/s41586‐021‐04019‐8 ↗
29. 10.3390/ijms2117624110.3390/ijms21176241 ↗
30. 10.1038/s41467‐019‐12988‐810.1038/s41467‐019‐12988‐8 ↗
31. 10.1152/ajpendo.00741.200910.1152/ajpendo.00741.2009 ↗
32. 10.1016/j.envpol.2023.12134710.1016/j.envpol.2023.121347 ↗
33. 10.1186/s12989‐020‐00356‐010.1186/s12989‐020‐00356‐0 ↗
34. 10.1186/s12986‐022‐00694‐010.1186/s12986‐022‐00694‐0 ↗
35. 10.1152/ajpendo.00600.200910.1152/ajpendo.00600.2009 ↗
36. 10.1038/s41598‐018‐33438‐310.1038/s41598‐018‐33438‐3 ↗
37. 10.1016/j.cmet.2020.11.00810.1016/j.cmet.2020.11.008 ↗
38. 10.1016/j.carbpol.2024.12263110.1016/j.carbpol.2024.122631 ↗
39. 10.1042/BJ2011141610.1042/BJ20111416 ↗
40. 10.1073/pnas.080562110510.1073/pnas.0805621105 ↗
41. 10.1172/JCI13731510.1172/JCI137315 ↗
42. 10.1038/nrendo.2017.8010.1038/nrendo.2017.80 ↗
43. 10.1038/s41467‐022‐33693‐z10.1038/s41467‐022‐33693‐z ↗
44. 10.3390/biom1212175510.3390/biom12121755 ↗
45. 10.1016/j.molmet.2015.10.00110.1016/j.molmet.2015.10.001 ↗
46. 10.1161/CIRCULATIONAHA.120.05063510.1161/CIRCULATIONAHA.120.050635 ↗
47. 10.1016/j.cmet.2016.03.01210.1016/j.cmet.2016.03.012 ↗
48. 10.1172/JCI17658610.1172/JCI176586 ↗
49. 10.1055/s‐2007‐100126010.1055/s‐2007‐1001260 ↗
50. Clinical Association of Circulating VEGF‐B Levels with Hyperlipidemia and Target Organ Damage in Type 2 Diabetic Patients
51. 10.3390/ijms2314752410.3390/ijms23147524 ↗
52. 10.1161/CIRCRESAHA.124.32518710.1161/CIRCRESAHA.124.325187 ↗
53. 10.1016/j.preteyeres.2021.10095410.1016/j.preteyeres.2021.100954 ↗
54. 10.3389/fcvm.2018.0003910.3389/fcvm.2018.00039 ↗
55. 10.1038/nm0603‐66910.1038/nm0603‐669 ↗
56. 10.1084/jem.2017101210.1084/jem.20171012 ↗
57. 10.3390/ijms2409836210.3390/ijms24098362 ↗
58. 10.1038/s42255‐022‐00667‐w10.1038/s42255‐022‐00667‐w ↗
59. 10.1038/s41420‐022‐00818‐810.1038/s41420‐022‐00818‐8 ↗
60. 10.1172/jci.insight.13916010.1172/jci.insight.139160 ↗
61. 10.1002/ptr.745110.1002/ptr.7451 ↗
62. 10.1080/0895837059091274310.1080/08958370590912743 ↗
63. 10.1289/ehp.9510317210.1289/ehp.95103172 ↗
64. 10.1038/s42255‐021‐00520‐610.1038/s42255‐021‐00520‐6 ↗
65. 10.1016/j.cell.2022.02.00410.1016/j.cell.2022.02.004 ↗
66. 10.1289/EHP1164610.1289/EHP11646 ↗